Cargando…

Endocan: A Key Player of Cardiovascular Disease

Endothelial dysfunction is considered to be an early change in atherosclerosis. Endocan, also known as endothelial cell specific molecule-1, is a soluble proteoglycan mainly secreted by endothelial cells. Inflammatory factors such as IL-1β and TNF-α can up regulate the expression of endocan and then...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jinzhi, Jiang, Liping, Yu, Xiao-Hua, Hu, Mi, Zhang, Yang-Kai, Liu, Xin, He, Pingping, Ouyang, Xinping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766991/ https://www.ncbi.nlm.nih.gov/pubmed/35071362 http://dx.doi.org/10.3389/fcvm.2021.798699

Ejemplares similares

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
por: Velmurugan, Ganesan, et al.
Publicado: (2022)

Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
por: Li, Junyi, et al.
Publicado: (2021)

Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4
por: Xiao, Zheng, et al.
Publicado: (2020)

Midkine—A novel player in cardiovascular diseases
por: Majaj, Marina, et al.
Publicado: (2022)

The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial
por: Burneikaitė, Greta, et al.
Publicado: (2023)

Hypoxia Inducible Factors as Central Players in the Pathogenesis and Pathophysiology of Cardiovascular Diseases
por: Lucero García Rojas, Emilio Y., et al.
Publicado: (2021)

Dietary precursors and cardiovascular disease: A Mendelian randomization study
por: Jing, Wangwei, et al.
Publicado: (2023)

A Cardiovascular Disease Prediction Model Based on Routine Physical Examination Indicators Using Machine Learning Methods: A Cohort Study
por: Qian, Xin, et al.
Publicado: (2022)

The genetic correlation and causal association between key factors that influence vascular calcification and cardiovascular disease incidence
por: Ni, Xiaolin, et al.
Publicado: (2023)

Circulating endocan and preeclampsia: a meta-analysis
por: Lan, Xia, et al.
Publicado: (2020)

Early growth response-1: Key mediators of cell death and novel targets for cardiovascular disease therapy
por: Xie, Yixin, et al.
Publicado: (2023)

WNT3A rs752107(C > T) Polymorphism Is Associated With an Increased Risk of Essential Hypertension and Related Cardiovascular Diseases
por: Ren, Huan, et al.
Publicado: (2021)

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
por: Lu, Yingdong, et al.
Publicado: (2022)

Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases
por: Teng, Teng, et al.
Publicado: (2022)

Network-Based Approach and IVI Methodologies, a Combined Data Investigation Identified Probable Key Genes in Cardiovascular Disease and Chronic Kidney Disease
por: Ahmed, Mohd Murshad, et al.
Publicado: (2022)

Pyroptosis: Role and Mechanisms in Cardiovascular Disease
por: Chen, Xinzhe, et al.
Publicado: (2022)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

A systematic review and meta-analysis of cold exposure and cardiovascular disease outcomes
por: Fan, Jie-Fu, et al.
Publicado: (2023)

MicroRNAs: New Players in the Pathobiology of Preeclampsia
por: Bounds, Kelsey R., et al.
Publicado: (2017)

Protective Potential of Maresins in Cardiovascular Diseases
por: Liu, Min, et al.
Publicado: (2022)

WGCNA combined with machine learning algorithms for analyzing key genes and immune cell infiltration in heart failure due to ischemic cardiomyopathy
por: Kong, XiangJin, et al.
Publicado: (2023)

CircHIPK3 Plays Vital Roles in Cardiovascular Disease
por: Zhang, Lei, et al.
Publicado: (2021)

Commentary: Plaque Features and Epicardial Fat Volume for Cardiovascular Risk Assessment—A Key Role With Cardiac Computed Tomography?
por: Tesche, Christian, et al.
Publicado: (2022)

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
por: Hua, Cun-Cun, et al.
Publicado: (2022)

Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
por: Bhaskar, Sonu, et al.
Publicado: (2020)

Associations Between Serum Soluble α-Klotho and the Prevalence of Specific Cardiovascular Disease
por: Xu, Jun-Peng, et al.
Publicado: (2022)

Association between hypertriglyceridemic-waist phenotype and cardiovascular disease: A cohort study and meta-analysis
por: Zheng, Xiaowei, et al.
Publicado: (2022)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
por: Chen, Yinong, et al.
Publicado: (2021)

The role of CD74 in cardiovascular disease
por: Li, Qiu-Lin, et al.
Publicado: (2023)

Endocan and Erectile Dysfunction
por: Balta, Sevket, et al.
Publicado: (2019)

Editorial: Exosomes in cardiovascular diseases: Mechanism, diagnosis, and therapy
por: Zhang, Xiao, et al.
Publicado: (2022)

The Association Between Exposure to Acrylamide and Mortalities of Cardiovascular Disease and All-Cause Among People With Hyperglycemia
por: Wu, Huanyu, et al.
Publicado: (2022)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Critical roles of m(6)A methylation in cardiovascular diseases
por: Zhang, Xinmin, et al.
Publicado: (2023)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

J-shaped association between serum albumin levels and long-term mortality of cardiovascular disease: Experience in National Health and Nutrition Examination Survey (2011–2014)
por: Li, Xu, et al.
Publicado: (2022)

Cardiovascular Changes in Patients With COVID-19 From Wuhan, China
por: Song, Limin, et al.
Publicado: (2020)

Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases
por: Li, Le, et al.
Publicado: (2021)

The role of lncRNA-mediated pyroptosis in cardiovascular diseases
por: Hu, Bo, et al.
Publicado: (2023)

DPP3: From biomarker to therapeutic target of cardiovascular diseases
por: Ye, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a0ef0bognlrt2ul56j3v473cea